Literature DB >> 22367883

Cervical screening in England: the past, present, and future.

Rebecca Albrow1, Henry Kitchener, Nalini Gupta, Mina Desai.   

Abstract

Cervical screening in England commenced in a disorganized fashion in 1964. The flaws of this approach became apparent in the mid-1980s and led to the inception of the National Health Service Cervical Screening Programme (NHSCSP). The main features of this program are its population-based registry, accessibility to all women within the screening age range, its systematic process of call and recall, national coordination, and quality assurance. Its success is in part based on its ability to evolve as evidence necessitates, and throughout the period of 2000-2010, it embarked upon a series of developments involving liquid-based cytology, which also provided the means to conduct reflex high-risk human papillomavirus (HR-HPV) testing and the potential to automate the screening process. As a result of evidence acquired since 2000, the NHSCSP is currently based on a system of primary cytology with HPV triage for low-grade abnormalities combined with cytology plus a HR-HPV "test of cure" for women who have received treatment for cervical intraepithelial neoplasia. Future challenges for the program will involve finding solutions to increasing screening uptake among women <30 years of age-a problem that may be exacerbated when vaccinated women reach the screening age, while making plans to accommodate HPV primary screening.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22367883     DOI: 10.1002/cncy.20203

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  12 in total

1.  Quantitative assessment of the relationship between p21 Ser31Arg polymorphism and cervical cancer.

Authors:  Yingchun Ma; Yanwei Zhang; Li Lin; Xiumin Guo; Yu Wu; Wenjuan Wen; Fengli Li; Peishu Liu
Journal:  Tumour Biol       Date:  2013-07-07

Review 2.  Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.

Authors:  M Saraiya; M Steben; M Watson; L Markowitz
Journal:  Prev Med       Date:  2013-02-08       Impact factor: 4.018

3.  Engaging Canadian First Nations Women in Cervical Screening through Education.

Authors:  Ingeborg Zehbe; Pamela Wakewich; Brianne Wood; Pauline Sameshima; Yvonne Banning; Julian Little
Journal:  Int J Health Promot Educ       Date:  2016-05-03

4.  Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey.

Authors:  Rachael H Dodd; Kirsten J McCaffery; Laura A V Marlow; Remo Ostini; Gregory D Zimet; Jo Waller
Journal:  Sex Transm Infect       Date:  2014-01-09       Impact factor: 3.519

5.  Colposcopy attendance and deprivation: A retrospective analysis of 27,193 women in the NHS Cervical Screening Programme.

Authors:  E Douglas; J Wardle; N J Massat; J Waller
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

6.  Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.

Authors:  Kirsten Rozemeijer; Steffie K Naber; Corine Penning; Lucy I H Overbeek; Caspar W N Looman; Inge M C M de Kok; Suzette M Matthijsse; Matejka Rebolj; Folkert J van Kemenade; Marjolein van Ballegooijen
Journal:  BMJ       Date:  2017-02-14

7.  Frequency of L-SIL and H-SIL Findings in HPV Positive Women.

Authors:  Amir Asotic; Suada Taric; Jasminka Asotic
Journal:  Mater Sociomed       Date:  2014-04-11

8.  Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.

Authors:  Kirsten Rozemeijer; Corine Penning; Albert G Siebers; Steffie K Naber; Suzette M Matthijsse; Marjolein van Ballegooijen; Folkert J van Kemenade; Inge M C M de Kok
Journal:  Cancer Causes Control       Date:  2015-10-12       Impact factor: 2.506

Review 9.  Frequency of unsatisfactory cervical cytology smears in cancer screening of Japanese women: A systematic review and meta-analysis.

Authors:  Satoyo Hosono; Teruhiko Terasawa; Takafumi Katayama; Seiju Sasaki; Keika Hoshi; Chisato Hamashima
Journal:  Cancer Sci       Date:  2018-03-31       Impact factor: 6.716

10.  Cervical cancer in Zimbabwe: a situation analysis.

Authors:  Oppah Kuguyo; Alice Matimba; Nomsa Tsikai; Thulani Magwali; Mugove Madziyire; Muchabayiwa Gidiri; Collet Dandara; Charles Nhachi
Journal:  Pan Afr Med J       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.